Sibutramine: Its mode of action and efficacy

International Journal of Obesity

Volumn 26, Issue , 2002, Pages S29-S33

  Finer, N ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Mechanism of action; Predictors of success; Sibutramine; Weight loss

Indexed keywords

ANTIOBESITY AGENT; SIBUTRAMINE;

BODY WEIGHT; CLINICAL PRACTICE; CONFERENCE PAPER; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; FOOD INTAKE; HUMAN; LIFESTYLE; LONG TERM CARE; METABOLISM; NEUROCHEMISTRY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT REDUCTION;

APPETITE DEPRESSANTS; CYCLOBUTANES; ENERGY METABOLISM; HUMANS; OBESITY; PROGNOSIS; WEIGHT LOSS;

EID: 0036945748     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802216     Document Type: Article

References (20)

1. Chapelot D, Marmonier C, Thomas F, Hanotin C. Modalities of the food intake-reducing effect of sibutramine in humans. Physiol Behav 2000; 68: 299–308.
2. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998; 6: 1–11.
3. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord 1999; 23: 1016–1024.
4. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup AV. Thermogenic effects of sibutramine in humans. Am J Clin Nutr 1998; 68: 1180–1186.
5. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119–2125.
6. Smith IG, Goulder MA. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract 2001; 50: 505–512.
7. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB. Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189–198.
8. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999; 106: 179–184.
9. Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999; 159: 1104–1109.
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002; 346: 393–403.
11. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaaniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 2001; 344: 1343–1350.
12. Kolotkin RL, Head S, Hamilton M, Tse CK. Assessing impact of weight on quality of life. Obes Res 1995; 3: 49–56.
13. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 1992; 116: 535–539.
14. Largerstrand L, Rossner S. Effects of weight loss on pulmonary function in obese men with obstructive sleep apnoea syndrome. J Intern Med 1993; 234: 245–247.
15. Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. Br Med J 2000; 320: 827–832.
16. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of 1-year follow up. Br Med J 1992; 304: 1015–1019.
17. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never smoking overweight US white women aged 40–64 years. Am J Epidemiol 1995; 141: 1128–1141.
18. Astrup A, Toubro S. When, for whom and how to use sibutramine. Int J Obes Relat Metab Disord 2001; 25(S4): S2–S7.
19. Hansen DL, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rössner S, Saris WHM, Van Gaal LF, James WPT, Goulder M for the STORM study group. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Int J Obes Relat Metab Disord 2001; 25: 496–501.
20. Finer N. Sibutramine in clinical practice. Int J Obes Relat Metab Disord 2001; 25(Suppl 4): S12–S15.